SLC12A3 and acidosis disorder: A clinical difference between the two syndromes relates to acid-base disturbances; Kir4.1 mutations invariably cause alkalosis, secondary to NCC inhibition, while Kir5.1 mutations are more variable with a subset of patients presenting with acidosis while others have alkalosis.